We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+9.33%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+596.65%
AUM
$759B
AUM Growth
+$62.2B
Cap. Flow
+$8.76B
Cap. Flow %
1.15%
Top 10 Hldgs %
15.99%
Holding
7,423
New
754
Increased
2,939
Reduced
2,285
Closed
593
Avg Time Held Equity + Options
17.2 quarters
Top 10 Avg Time Held Equity + Options
15.7 quarters
Top 20 Avg Time Held Equity + Options
12.9 quarters
Avg Time Held Equity only
18.8 quarters
Top 10 Avg Time Held Equity only
15.7 quarters
Top 20 Avg Time Held Equity only
15.1 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.19%
2 Technology 14.28%
3 Healthcare 12.84%
4 Financials 10.61%
5 Consumer Discretionary 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
JWAC
6951
DELISTED
Jupiter Wellness Acquisition Corp. Class A Common Stock
JWAC
– –
-99,500
Closed -$999K –
BLCM
6952
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$0 ﹤0.01%
+1
New +$1
2022 Q4
0 quarters
LABP
6953
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$0 ﹤0.01%
61
-163
-73% -$624
2021 Q1
7 quarters
SEAC
6954
DELISTED
Seachange International Inc
SEAC
$0 ﹤0.01%
6
– –
2022 Q3
1 quarter
LVAC
6955
DELISTED
LAVA Medtech Acquisition Corp. Class A Common Stock
LVAC
– –
-275,091
Closed -$2.77M –
IMV
6956
DELISTED
IMV Inc. Common Shares
IMV
– –
-3,000
Closed -$16K –
LMST
6957
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
$0 ﹤0.01%
8
– –
2020 Q2
10 quarters
SKYA
6958
DELISTED
Skydeck Acquisition Corp. Class A Ordinary Shares
SKYA
– –
-151,110
Closed -$1.49M –
BMAQ
6959
DELISTED
Blockchain Moon Acquisition Corp. Common Stock
BMAQ
– –
-145,000
Closed -$1.45M –
CIH
6960
DELISTED
China Index Holdings Limited American Depository Shares
CIH
$0 ﹤0.01%
262
– –
2019 Q2
14 quarters
ARVL
6961
DELISTED
Arrival Ordinary Shares
ARVL
– –
-1,884
Closed -$44.8K –
AMYT
6962
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$0 ﹤0.01%
2
– –
2021 Q1
7 quarters
AGRX
6963
DELISTED
Agile Therapeutics
AGRX
$0 ﹤0.01%
+6
New +$70
2022 Q4
0 quarters
CDAK
6964
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$0 ﹤0.01%
79
-1,299
-94% -$855
2020 Q4
8 quarters
TWNI
6965
DELISTED
Tailwind International Acquisition Corp.
TWNI
– –
-300,000
Closed -$2.98M –
AGFS
6966
DELISTED
AgroFresh Solutions Inc
AGFS
– –
-12
Closed – –
ASPU
6967
DELISTED
ASPEN GROUP, INC.
ASPU
$0 ﹤0.01%
1
-40,638
-100% -$14.7K
2020 Q2
10 quarters
ISDX
6968
DELISTED
Invesco Exchange-Traded Self-Indexed Fund Trust Invesco RAFI Strategic Developed ex-US ETF
ISDX
– –
-311
Closed -$7K –
MSDA
6969
DELISTED
MSD Acquisition Corp. Class A Ordinary Shares
MSDA
$0 ﹤0.01%
1
– –
2022 Q2
2 quarters
TETC
6970
DELISTED
Tech and Energy Transition Corporation Class A Common Stock
TETC
– –
-100,000
Closed -$986K –
ATCO
6971
PUT
DELISTED
Atlas Corp.
ATCO
– –
-80,000
Closed -$1.11M –
LDHA
6972
DELISTED
LDH Growth Corp I Class A Ordinary Shares
LDHA
– –
-599,997
Closed -$5.95M –
QTT
6973
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$0 ﹤0.01%
+66
New +$36
2022 Q4
0 quarters
IAA
6974
CALL
DELISTED
IAA, Inc. Common Stock
IAA
– –
-154,600
Closed -$4.92M –
ALR
6975
DELISTED
AlerisLife Inc
ALR
$0 ﹤0.01%
175
– –
2020 Q1
11 quarters

Similar funds

JP Morgan Chase's Q4 2022 Portfolio in Review

As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.

  • JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
  • JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
  • JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
  • JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
  • JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
  • JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
  • JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.

Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.